文献速递结核与非结核分枝杆菌

中国东部结核病再感染与复发:一项应用全基因组测序的前瞻性研究

Tuberculosis reinfection and relapse in eastern China: a prospective study using whole-genome sequencing.
PubMed 文献 · Clin Microbiol Infect · 2022-06-11

在江苏省五市纳入2013至2015年培养阳性且治疗成功的肺结核患者并随访2年,7.4%(141/1879)出现复发。全基因组测序以6个单核苷酸多态性为距离阈值区分复发与再感染,复发(71.1%)显著多于再感染(28.9%),高龄、既往结核治疗史和双侧空洞与复发风险升高相关。

要点

  • 治疗成功后2年内7.4%(141/1879)出现结核复发。
  • 测序可配对者中复发71.1%显著高于再感染28.9%(p=0.014)。
  • 高龄、既往结核治疗史和双侧空洞与复发风险升高相关。

核心结论

  • 在中国东部,治疗成功后2年内内源性复发显著多于外源性再感染。
  • 对高龄、既往有结核诊断史或双侧空洞等高复发风险人群进行优先管理,可能为降低结核后疾病负担提供机会。

研究设计与样本

  • 前瞻性研究,2013至2015年从江苏省五市招募培养阳性且治疗成功的肺结核患者,随访2年观察结核复发。
  • 对出现第二次结核发作的患者进行全基因组测序,以6个单核苷酸多态性为距离阈值区分复发与再感染。
  • 分析复发危险因素及不同类型复发患者的流行病学特征。

主要发现

  • 1897例治疗成功的结核患者中,7.4%(141/1879)出现结核复发。
  • 与无复发患者相比,年龄较大者复发风险更高(每增加1岁,调整比值比1.02;95%CI 1.01至1.03,p=0.003)。
  • 既往接受过结核治疗者复发风险更高(调整比值比2.22;95%CI 1.52至3.26,p<0.001)。
  • 有双侧空洞者复发风险更高(调整比值比1.56;95%CI 1.05至2.32,p=0.029)。
  • 在27.0%(38/141)测序配对成功的复发患者中,复发显著多于再感染(71.1% vs 28.9%,p=0.014)。

关键数值与推荐

  • 全基因组测序以6个单核苷酸多态性为距离阈值区分复发与再感染。
  • 复发定义为治疗成功后出现第二次结核发作。

临床怎么用

  • 作者认为,对高龄、既往有结核诊断史或双侧空洞等高复发风险人群进行优先管理,可能为降低结核后疾病负担提供机会。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Tuberculosis recurrence after an initial successful treatment episode can occur from either reinfection or relapse. In a population-based sample and whole genome sequencing in eastern China, we aimed to evaluate risk factors for tuberculosis recurrence and assess the proportion of recurrence because of either reinfection or relapse. METHODS: Successfully treated pulmonary tuberculosis patients with sputum culture positive results were recruited from five cities in Jiangsu Province from 2013 to 2015 and followed for 2 years for tuberculosis recurrence. Among patients developing a second tuberculosis episode, whole genome sequencing was performed to distinguish relapse or reinfection through a distance threshold of 6-single-nucleotide polymorphisms. We analyzed risk factors for recurrence and epidemiological characteristics of different types of recurrent patients. RESULTS: Of 1897 successfully treated tuberculosis patients, 7.4% (141/1879) developed recurrent tuberculosis. Compared with nonrecurrent tuberculosis, patients were at higher risk of recurrence in older age (adjusted odds ratio, 1.02 for each additional year; 95% CI, 1.01 to 1.03, p = 0.003), patients previously treated for tuberculosis (adjusted odds ratio = 2.22; 95% CI, 1.52 to 3.26, p < 0.001), or with bilateral cavities (adjusted odds ratio, 1.56; 95% CI, 1.05 to 2.32, p = 0.029). Among 27.0% (38/141) recurrent tuberculosis patients with successfully sequenced pairs, relapse was substantially more common than reinfection (71.1% vs 28.9%, p = 0.014). DISCUSSION: Endogenous relapse was significantly more common than exogenous reinfection in the first 2 years after treatment in eastern China. Prioritization of high-risk groups for recurrence, such as the elderly, with a previous tuberculosis diagnosis, or with bilateral cavities, may provide opportunities to reduce post-tuberculosis morbidity.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Liu Q, Qiu B, Li G, et al. Tuberculosis reinfection and relapse in eastern China: a prospective study using whole-genome sequencing. Clin Microbiol Infect. 2022. PMID: 35700940. doi:10.1016/j.cmi.2022.05.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。